$19.68
0.0050.03%
最終更新: Oct 22, 10:55 AM
$19.67
N/A
Benzinga
Benzinga
Benzinga
木曜日, 10 22
Benzinga
© 2026 Benzinga | All Rights Reserved
Silence Therapeutics (SLN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.15 | $-0.21 | $-0.43 | $-0.28 |
| Actual | $-0.09 | $-0.11 | $-0.27 | $-0.45 |
| Surprise | +40.0% | +47.6% | +37.2% | -60.7% |
| Revenue | ||||
| Estimate | $1.3M | $2.4M | $6.7M | $4.4M |
| Actual | $0 | $422000 | $34000 | $159000 |
| Surprise | -100.0% | -82.7% | -99.5% | -96.4% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.12 | $-0.14 | $-0.33 | $-0.36 |
| Revenue | ||||
| Consensus | $20830 | $4500 | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.09 | $-0.15 | 40.0 % |
| Q1 | May 7, 2026 | $-0.11 | $-0.21 | 47.6 % |
| Q4 | Mar 5, 2026 | $-0.27 | $-0.43 | 37.2 % |
| Q3 | Nov 6, 2025 | $-0.45 | $-0.28 | -60.7 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $0 | $1.33M | -100.0 % |
| Q1 | May 7, 2026 | $422.00K | $2.44M | -82.7 % |
| Q4 | Mar 5, 2026 | $34.00K | $6.73M | -99.5 % |
| Q3 | Nov 6, 2025 | $159.00K | $4.41M | -96.4 % |